Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 24 tags : Europe save search
$1.03 billion Growth Expected in Automotive Brake Wear Sensors Market|Europe to Notice Maximum Growth|Technavio
Published: 2021-05-24 (Crawled : 00:00) - prnewswire.com
ST | $33.755 -0.66% 88K
|
Electronic Technology
|
| O: 0.33%
H: 0.84%
C: -1.78%
BWA | $32.84 -0.88% 130K
|
Producer Manufacturing
|
| O: 0.12%
H: 1.12%
C: -0.82%
europe sensor growth
$ 1.23 Bn growth in Audiobook Market in Europe | Benefits and Reader Engagement of Audiobooks to Boost Growth | Technavio
Published: 2021-05-24 (Crawled : 16:00) - prnewswire.com
AAPL | $172.43 -0.15% 12M
|
Electronic Technology
|
| O: 0.46%
H: 1.53%
C: 0.87%
GOOGL | $154.54 -0.21% 4.9M
|
Technology Services
|
| O: 0.9%
H: 2.19%
C: 1.99%
GOOG | $156.2 -0.08% 3.3M
|
Technology Services
|
| O: 0.93%
H: 2.17%
C: 1.68%
europe audio growth
Workforce Management Software Market in Europe to grow over $ 410 Mn during 2021-2025 | Need to Optimize and Organize the use of Workforce to boost growth | Technavio
Published: 2021-05-24 (Crawled : 15:15) - prnewswire.com
SAP | $180.86 0.35% 130K
|
Technology Services
|
| O: 0.95%
H: 0.67%
C: 0.18%
software europe growth
European Medicines Agency Grants BioMarin's Request for Accelerated Assessment of Valoctocogene Roxaparvovec for Treatment of Severe Hemophilia A
Published: 2021-05-24 (Crawled : 13:00) - investors.biomarin.com
BMRN S | $90.88 -0.69% 150K
|
Health Technology
|
| O: 0.67%
H: 0.36%
C: -1.36%
treatment europe granted grant
Spruce Biosciences Presents Phase 2 Data for Tildacerfont in Adults with Congenital Adrenal Hyperplasia at 23rd European Congress of Endocrinology
Published: 2021-05-24 (Crawled : 13:00) - biospace.com/
SPRB | $0.7132 -3.12% 430K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -5.71%
phase 2 europe renal
Nanomerics announces patents granted in the US, Europe and Japan and two key publications on the ocular use of its Molecular Envelope Technology
Published: 2021-05-24 (Crawled : 07:00) - biospace.com/
VRPX | $3.5303 970
|
|
| O: -1.27%
H: 0.32%
C: -2.38%
europe ocular molecular patent technology
Libtayo® (cemiplimab) Receives Positive CHMP Opinion for the Treatment in Europe of Two Advanced Cancers
Published: 2021-05-24 (Crawled : 06:00) - prnewswire.com
SNY | $46.2 0.59% 210K
|
Health Technology
|
| O: 0.02%
H: 0.3%
C: -0.3%
REGN | $895.56 -0.33% 120K
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: -1.82%
treatment europe positive cancer chmp
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
TPET | $0.503 117.66% 21M
|
n/a
JAGX | $0.23 93.6% 310M
|
Health Technology
WISA 4 | $3.22 84.0% 56M
|
Electronic Technology
SXTC | $2.56 82.86% 11M
|
Health Technology
PALI | $6.57 57.93% 19M
|
Manufacturing
BTTR | $7.61 49.22% 1.8M
|
Manufacturing
PRSO | $1.79 40.95% 38M
|
Manufacturing
DYNT | $0.5203 40.47% 17M
|
Health Technology
MCBC | $13.755 38.52% 620K
|
Finance
SNGX | $0.51 32.09% 6.3M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.